Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis

Published:2013-11-20 Issue:12 Volume:18 Page:1248-1255
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Yin Ming¹,Zhou Jie²,Gorak Edward J.³,Quddus Fahd³

Affiliation:

1. Department of Internal Medicine, Danville, Pennsylvania, USA

2. Department of Radiology, Geisinger Medical Center, Danville, Pennsylvania, USA

3. Department of Hematology and Oncology, Geisinger Medical Center, Danville, Pennsylvania, USA

Abstract

Learning Objectives Describe the influences of different types of glucose-lowering medications on therapeutic outcomes of cancer patients who received standard anticancer treatment. Compare the survival associated with metformin treatment with survival in treatment with other glucose-lowering medications.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0111

Reference54 articles.

1. Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer;Richardson;Nat Clin Prac,2005

2. Diabetes and cancer: A consensus report;Giovannucci;Diabetes Care,2010

3. Metformin inhibits hepatic gluconeogenesis in mice independently of the lkb1/ampk pathway via a decrease in hepatic energy state;Foretz;J Clin Invest,2010

4. Metformin inhibits hepatic gluconeogenesis through amp-activated protein kinase-dependent regulation of the orphan nuclear receptor shp;Kim;Diabetes,2008

5. Metformin and pioglitazone: Effectively treating insulin resistance;Staels;Curr Med Res Opin,2006

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model;BMC Research Notes;2024-01-02

2. Thyroid cancer and insulin resistance;Reviews in Endocrine and Metabolic Disorders;2023-11-14

3. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01

4. Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor infiltrating lymphocytes in experimental carcinoma model;2023-09-27

5. Screening and Management Recommendations for Type 2 Diabetes in Women With Breast Cancer;Canadian Journal of Diabetes;2023-07